PT - JOURNAL ARTICLE AU - Hester, Kyra A AU - Sakas, Zoe AU - Ellis, Anna S. AU - Bose, Anindya Sekhar AU - Darwar, Roopa AU - Gautam, Jhalak AU - Jaishwal, Chandni AU - James, Hanleigh AU - Keskinocak, Pinar AU - Nazzal, Dima AU - Ogutu, Emily Awino AU - Rodriguez, Katie AU - Zunino, Francisco Castillo AU - Dixit, Sameer AU - Bednarczyk, Robert A. AU - Freeman, Matthew C. AU - , TI - Critical success factors for high routine immunization performance: A case study of Nepal AID - 10.1101/2022.01.28.22270023 DP - 2022 Jan 01 TA - medRxiv PG - 2022.01.28.22270023 4099 - http://medrxiv.org/content/early/2022/01/29/2022.01.28.22270023.short 4100 - http://medrxiv.org/content/early/2022/01/29/2022.01.28.22270023.full AB - Introduction The essential components of a vaccine delivery system are well-documented, but robust evidence on how and why the related processes and implementation strategies drive catalytic improvements in vaccination coverage are not well established. To address this gap, we identified critical success factors that may have led to substantial improvements in routine childhood immunization coverage in Nepal from 2000 through 2019.Methods We identified Nepal as an exemplar in the delivery of early childhood vaccines through analysis of DTP1 and DTP3 coverage data. Through interviews and focus group discussions at the national, regional, district, health post, and community level, we investigated factors that contributed to high and sustained vaccine coverage. We conducted a thematic analysis through application of implementation science frameworks to determine critical success factors. We triangulated these findings with quantitative analyses using publicly available data.Results The following success factors emerged: 1) Codification of health as a human right, along with other vaccine-specific legislation, ensured the stability of vaccination programming; 2) National and multi-national partnerships supported information sharing, division of labor, and mutual capacity building; 3) Pro-vaccine messaging through various mediums, which was tailored to local needs, generated public awareness; 4) Female Community Health Volunteers educated community members as trusted and compassionate neighbors; and 5) Cultural values fostered collective responsibility and community ownership of vaccine coverage.Conclusion This case study of Nepal suggests that the success of its national immunization program relied on the engagement and understanding of the beneficiaries. The immunization program was supported by consistent and reliable commitment, collaboration, awareness, and collective responsibility between the government, community, and partners. These networks are strengthened through a collective dedication to vaccination programming and a universal belief in health as a human right.Competing Interest StatementJhalak Guatam is the head of the National Immunization Programme of Nepal - which was critically assessed for this study - and he received a full-time salary for this work. He served as a participant in this research with his data anonymized. The remaining authors have no conflicts of interest to declare.Funding StatementThis work was supported by the Bill & Melinda Gates Foundation, Seattle, WA (OPP1195041) with a planning grant from Gates Ventures, LLC, Kirkland, WA.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was considered exempt by the Institutional Review Board committee of Emory University, Atlanta, Georgia, USA (IRB00111474) and the Nepal Health Research Council (NHRC; Reg. no. 347/2019) in Kathmandu, Nepal. All participants provided written informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified data are available upon request.